Position in ABVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,566,871
+$98,610 QoQ
Shares Held
11,758
-10.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#153
of 302 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FORA Capital, LLC holds $19,737,715 across 20 Biotechnology names. ABVX ranks #2 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,209 | $1,568,065 | |
| 2 | ABVX |
Abivax S.A.
This page
|
11,758 | $1,566,871 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
44,129 | $1,561,725 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
6,364 | $1,557,716 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
27,289 | $1,550,288 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
4,205 | $1,407,791 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,147 | $1,338,740 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
5,408 | $1,303,165 |
All Filings in ABVX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,566,871 | 11,758 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,468,261 | 13,186 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,059,825 | 7,859 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||